Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Chair File: Leadership Dialogue — Insights and Innovation in Rural Hospitals with Mark Boucot of Potomac Valley Hospital
Mark Boucot, CEO of Potomac Valley Hospital, a 25‑bed critical access facility in West Virginia, received the inaugural AHA Rural Hospital Excellence in Innovation Award. He highlighted the hospital’s low‑cost virtual ICU, built with simple tablets for remote intensivist support, and the integration of AI to streamline physician documentation. These initiatives have driven emergency department throughput, increased daily census to near‑full occupancy, and expanded specialty services. The hospital’s growth also generated 300 local jobs, reinforcing its role as a community health and economic anchor.
With Quantum Transformation Looming, No Time to Waste in Maturing Cryptography Management
Quantum computers can break RSA and ECC encryption in seconds, prompting urgent action for healthcare data security. At HIMSS26, DigiCert’s Mike Nelson and other experts will outline practical steps for post‑quantum cryptography (PQC) migration, emphasizing crypto agility and automated management....
Researchers Use Dynamic Digital Radiography to Quantify Functional Outcomes After Total Shoulder Arthroplasty
Emory Healthcare researchers used Konica Minolta's Dynamic Digital Radiography (DDR) to compare anatomic and reverse total shoulder arthroplasty (aTSA and rTSA) in 71 shoulders versus 32 healthy controls. The DDR cine‑loop analysis showed that both procedures restored scapulohumeral rhythm (SHR)...
Elevating the Role of Advanced Practice Providers in the Evolving Alzheimer Disease Landscape
Alzheimer disease is set to affect 152 million people by 2050, driving a trillion‑dollar economic burden. New anti‑amyloid monoclonal antibodies demand early, accurate diagnosis, prompting health systems to enlist advanced practice providers (APPs) for screening, treatment coordination, and caregiver support. Panels...
Why You Shouldn’t Panic About GLP-1 Muscle Loss
GLP‑1 agonists such as Wegovy are driving rapid weight loss, prompting concerns that users may experience significant muscle loss. While people with obesity typically possess more absolute muscle, weight reduction naturally sheds some lean tissue, and researchers have not yet...
New Deductible Rules Allow for $31,000 Out-of-Pocket Maximum
The Trump administration is proposing a rule that revives catastrophic, or "junk," health plans with a $31,000 family deductible, effectively undoing the ACA’s ban on such high‑deductible products. These plans, once sold by major insurers like Cigna, Aetna and UnitedHealthcare,...
Moderna’s Dual Covid-Flu Vaccine Poised for EMA Approval on Positive CHMP Take
The European Medicines Agency’s CHMP has issued a positive opinion on Moderna’s mCombriax, a combined COVID‑19 and influenza mRNA vaccine, after a Phase III trial showed stronger immune responses than a mixed regimen of Sanofi’s flu shot and Spikevax. EMA approval...
Other News to Note for March 2, 2026
At CROI 2026, researchers spotlighted the growing neurodegenerative burden among aging people living with HIV, emphasizing heightened risks of depression and cognitive vulnerability despite long‑term antiretroviral therapy. Parallelly, the University of Southern California announced a novel series of MAPT aggregation...
Virtual Crisis Care Helps Rural Communities Access Mental Health Resources in Emergencies
Virtual Crisis Care (VCC) programs give rural law enforcement instant video access to behavioral health clinicians, allowing real‑time assessment and de‑escalation of mental‑health emergencies. In South Dakota, the model has been active for over five years across more than 30...
In the Clinic for March 2, 2026
BioWorld’s “In the Clinic for March 2, 2026” page functions as a centralized gateway to the latest biopharma, med‑tech, and scientific content. It aggregates data snapshots, special reports, infographics, and market scorecards covering everything from GLP‑1 trends in China to mRNA vaccine...
Regulatory Actions for March 2, 2026
On March 2, 2026 BioWorld published a regulatory snapshot covering biopharma and med‑tech firms such as AS Software, Asieris, Boehringer Ingelheim, Deephealth, Eli Lilly, Ipsen, Moderna, Neurogene, Novartis, Optellum, Photocure, Regeneron, Sanofi, Sentynl, Synergy Spine Solutions and X4. The roundup highlights...
Optimism Boosts Longevity More Than Traditional Risk Factors
I taught my medical students about every risk factor for early death — smoking, obesity, diabetes, hypertension. I never once mentioned optimism. A PNAS study of two large epidemiologic cohorts found that the most optimistic people lived 11–15% longer on average —...
Pregnancy And Colon Cancer Share Symptoms, Often Delays Diagnosis.
Pregnant women may mistake colorectal cancer warning signs for normal pregnancy discomfort, leading to delayed diagnosis. Lori Charney’s case illustrates how constipation, abdominal pain and rectal bleeding were attributed to pregnancy until stage IV cancer was discovered postpartum. Experts note that...
Medicare's Continued Support for Telemedicine Signals Stability, Legitimacy
Medicare has extended its telehealth reimbursement flexibilities through 2027, preserving payment for a broad array of virtual services. Behavioral health telehealth restrictions were made permanent in 2021, removing geographic and originating‑site limits. The DEA also prolonged its telemedicine prescribing allowances...
Contributor: Personalized Heart Risk and How AI-Powered Plaque Analysis Is Changing Prevention
AI‑enhanced coronary CT angiography (CCTA) now quantifies total and non‑calcified plaque, delivering risk information that calcium scoring alone misses. Large studies show that incorporating AI‑driven plaque metrics reduces heart attack or cardiac death risk by up to 41% and boosts...
INN-Coming: Insights on the Industry’s Latest Disclosures
The WHO’s INN proposed list 134, released in early 2026, reveals several late‑stage drug candidates that were previously hidden from public view. Notably, two NLRP3 inhibitors—abdenoflast and parunoflast—appear to map to Eli Lilly’s newly acquired Ventyx assets VTX2735 and VTX3232, both showing promising...
Income Inequality Fuels Worsening Birth Outcomes
A new JAMA Pediatrics study using PRAMS data from 2012‑2022 examined 380,499 births and found that low‑income mothers experienced a widening gap in low‑birth‑weight infants, rising 2.2 percentage points versus a 0.6‑point increase for higher‑income groups. The analysis revealed that...
Why Novo Nordisk's Ireland Expansion Is Key to Fighting Off Eli Lilly
Novo Nordisk announced a €432 million ($506 million) investment to expand its Athlone, Ireland facility, increasing capacity for oral products such as the newly launched Wegovy pill. The expansion is intended to secure supply outside the United States and help the company...
Professor Launches Free Newsletter on Longevity Secrets
I'm excited to announce something new. After 30 years of teaching at UCLA and USC, I've started a newsletter called Health Longevity Secrets. Every week: what medical school gets wrong, how to read your labs, evidence-based longevity strategies. Free: http://robertlufkinmd.substack.com
Why One Iowa-Based Company Opened a Primary Care Clinic Near Its Office
Pella Corporation opened a wellness center five minutes from its Iowa headquarters, offering primary care, behavioral health, and pharmacy services to its 2,500 employees. The clinic was built in partnership with Premise Health, which designed a high‑touch, high‑tech model that...
Champion Insights Opens Nationwide Enrolment to Study ALS Risk in High-Performance Groups
Champion Insights has launched a nationwide enrollment to recruit up to 500 elite athletes, military veterans and first responders for a study investigating their elevated risk of amyotrophic lateral sclerosis (ALS). The remote study will collect blood samples and online...
HAP Foundation, Northwestern University Launch Palliative, Hospice Care Educational Initiative
The HAP Foundation and Northwestern University’s EPEC program have launched a 12‑month clinical training initiative aimed at Illinois‑based hospice and palliative care providers serving rural communities. Beginning in April, the curriculum combines monthly virtual video sessions with in‑person kickoff and...
Human Trust Beats AI in Patient Engagement
I keep seeing AI-pilled people arguing that AI agents will magically solve patient engagement - but it won’t. If it were that easy, non-Tech solutions would’ve solved it already. At @SeamlessMD, I’ve spent the last 13+ years working with health systems...
Bioresearch Monitoring Information System (BMIS)
The FDA’s Center for Drug Evaluation and Research has released the Bioresearch Monitoring Information System (BMIS), a searchable database that catalogs clinical investigators, contract research organizations, and institutional review boards linked to IND submissions since October 1, 2008. The dataset is updated...
Victoria Leeds Admits Randox Health for Regional Debut
Victoria Leeds, owned by Redical, announced that Randox Health will open its first standalone clinic in Yorkshire, occupying a 734 sq ft unit in the Victoria Quarter. The clinic will provide a full suite of blood tests, comprehensive health checks, specialised diagnostics...
Why I Stopped Accepting Pharmaceutical-Sponsored Lunches
Timothy Lesaca, a psychiatrist, stopped accepting pharmaceutical‑sponsored lunches, arguing they blur the line between patient care and industry influence. Recent CMS Open Payments data reveal over 1.1 million industry events in 2024, with 920 000 lunches costing $73 million. Research shows even a...
Medicare Advantage Reckoning Hits 2026 Enrollment: Mark Meiselbach, PhD
New research predicts that nearly 3 million Medicare Advantage (MA) enrollees—about 10 % of the market—will be forced out of their plans in 2026 as payment reforms curb historic over‑payments. The exits will hit rural beneficiaries hardest and will deepen the divide...
Ventricular Recovery Program Enables Kids to Have VADs Explanted
A standardized ventricular recovery program at Children’s Hospital of Philadelphia enabled 26% of pediatric VAD patients to have the device explanted, far exceeding the typical 4‑6% national rate. The protocol, built on four pillars—mindset, goal‑directed medical therapy, standardized surveillance, and...
Looking Beyond AI Implementation at HIMSS26
HIMSS CEO Hal Wolf announced that the AI track at HIMSS26 will move beyond pure deployment discussions. The conference will spotlight AI governance frameworks, the impact on clinical and administrative workflows, and concrete methods for calculating return on investment. By...
CPHI Middle East 2026 | 11-13 May, Riyadh
CPHI Middle East will return to Riyadh in May 2026, building on the 2024 edition that attracted over 30,000 visitors from more than 100 countries. The event promises expanded networking opportunities, direct market access, and the latest regulatory and innovation...
The Paper-Thin Implant That Listens To Your Brain Signals
Researchers published in Nature Electronics a hair‑thin, flexible patch called BISC that places 65,536 micro‑electrodes on the brain’s surface for high‑resolution electrocorticography. The device can address up to 1,024 channels simultaneously and transmits data wirelessly, eliminating percutaneous cables. Animal tests...
Virtual Reality Takes Next Step in Eye Care
Virtual reality is moving from experimental demos to practical tools in ophthalmology, highlighted by the FDA‑cleared Luminopia therapy for amblyopia and patient‑focused IOL simulators such as VirtuaLens and InSightVR. Surgeons are adopting VR for training, with platforms like Eyesi and...
Victoria Leeds Admits Randox Health for Regional Debut
Victoria Leeds, operated by Redical, has secured Randox Health for its first standalone clinic in Yorkshire, occupying a 734 sq ft space in the Victoria Quarter. The new clinic will provide a full suite of preventative health services, including comprehensive blood tests,...
Johnson & Johnson Launches 3 New Stroke Devices
Johnson & Johnson MedTech launched three new stroke devices—Cereglide 42 and Cereglide 57 aspiration catheters and the Innerglide 7 delivery aid—expanding its aspiration‑first portfolio. The catheters feature a multi‑axial shaft, radiopaque tips and hydrophilic coating to improve navigation of distal clots. Innerglide 7 provides...
Ozempic Reverses Osteoarthritis Cartilage Damage, Study Shows
I used to teach that osteoarthritis was "wear and tear" — lose weight, take painkillers, wait for a knee replacement. A study just published in Cell Metabolism proved that wrong. Semaglutide (Ozempic) didn't just reduce joint pain in osteoarthritis patients — it...
Set Up Your Clinic on Glass in Minutes
Onboarding your team or clinic to a new AI tool is so important, but often difficult. At Glass, we've made it incredibly easy — you can now get your whole clinic set up in a few minutes.
Bioxytran Reports Positive Phase 1b/2a Results for Antiviral ProLectin‑M
Bioxytran announced positive phase 1b/2a data for its oral antiviral ProLectin‑M in a randomized, double‑blind, placebo‑controlled trial of 39 mild‑to‑moderate COVID‑19 patients in India. The highest dose (16,800 mg/day) achieved viral clearance in 90% of participants by day 5 versus 20% on placebo,...
AI Computes Freely, Humans Bear the Cost of Errors
🚨Computation Without Consequence 👉A clinical study reveals the divide between AI computation and human judgment. 📌AI handles patterns with ease. 📌Humans feel the weight of being wrong. 📌That’s where the divide becomes clear and important. https://t.co/tjfOTsWnCC #AI #medicine #digitalhealth
GLP‑1 Weight‑Loss Drugs Work Better for Women
A systematic RCT analysis of GLP-1 drugs show they are more effective in women than men for weight loss https://t.co/cycwi4nnN5 https://t.co/KOl0FgKaZD
Article Intro - SurgRAW: Multi-Agent Workflow for Robotic Surgical Video Analysis
IEEE Robotics and Automation Letters introduces SurgRAW, a multi‑agent, chain‑of‑thought workflow designed for zero‑shot reasoning on robotic surgical video. The system builds on SurgCoTBench, a new benchmark with 14,256 question‑answer pairs and frame‑level annotations across five core surgical tasks. By...
Roche's MS Drug Shows Promise, Approval Still Uncertain
Roche pill succeeds in another MS study, but approval questions linger https://t.co/JY8uZCI5iA @ByJonGardner $RHHBY $SNY
FDA Demands Extra Study for UniQure's Huntington Gene Therapy
UniQure says FDA wants another study of Huntington’s gene therapy https://t.co/1pgFDoE2V9 by @realJacobBell $QURE - 35% #GeneTherapy #Huntingtonsdisease
AI Pathology for Cancer Markers Hindered by Shortcut Learning
AI of whole slide images for cancer molecular markers is not ready for clinical use due to confounding and biases ("shortcut learning"), supported by multiple examples @natBME https://t.co/zG8uVIxrJf https://t.co/hQ0tjiapIJ
Exercise‑derived Muscle Vesicles Boost Brain Microglia, Improve Cognition
A new mechanism for improved cognitive function from exercise in the Alzheimer's disease model Skeletal muscle EC vesicles interact with the brain and rev up microglia function https://t.co/eZu14YVasY
Consolidation Saves Space, But Disrupts Clinical Documentation Trust
System consolidation looks efficient—until you count the cost of disruption. Strong view from @Provationmed on why migrating away from purpose-built clinical documentation puts adoption, revenue, and trust at risk. ➡️ https://t.co/WahjLaV8Wl #ClinDoc #CIOInsights #HITSM
Aardvark Pauses Pivotal Prader‑Willi Trial over Safety
Safety concerns spur Aardvark to halt key Prader-Willi drug trial https://t.co/PWkOuDMIvo $AARD - 52% $SLNO
Vaccine Pioneer Warns: We’re Heading Downhill.
Stanley Plotkin, known as the “godfather of vaccines,” in an interview with @HelenBranswell: “All I can say is that I’m beginning to regret having lived so long — because we’re going downhill.” https://t.co/A2zcoP2Ghd
Antibody Plus Ozempic Drives Significant Weight Loss
New @NatureMedicine A randomized trial of antibody vs activin type II receptors with or without semaglutide (Ozempic). The antibody, bimagrumab, promotes muscle growth. Marked weight loss with the combination https://t.co/XUK93GTAmA
Veteran Vaccine Pioneer Warns of Eroding Confidence
Stanley Plotkin had a major hand in the development of a number of vaccines in use today; he designed the rubella vaccine. He remembers the world before widespread use of vaccines & knows what's coming as vaccine policy is rewritten...
Future: Real-Time Immune Monitoring Like Glucose Tracking
Someday we'll be able to track our immune system like we do glucose Today @NatBME https://t.co/HFcFiUeyFg Previously @ScienceMagazine https://t.co/EcgBdwGxcd https://t.co/SpoZ5bLtjx